Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Pancreas-associated transcription factor 1a (PTF1A) is a pancreas-restricted transcription factor of the basic helix-loop-helix (bHLH) family, serving as a key component of the multiprotein PTF1 complex. It is indispensable for pancreas development, guiding progenitor cells toward pancreatic organogenesis, acinar cell differentiation, and maintaining transcriptional programs for exocrine function. In addition to pancreatic roles, PTF1A is crucial for the proper specification of certain neural cell lineages, notably in the cerebellum. Loss-of-function mutations or regulatory disruption result in severe developmental defects such as pancreatic and cerebellar agenesis, neonatal diabetes, and exocrine insufficiency. Dysregulation can also contribute to pancreatic cancer, highlighting its importance as a tumor suppressor[1][2][3].
PTF1A is not a direct drug target; therapeutic modulation would likely be via gene/protein expression or activity, but this is experimental, not clinical practice.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Pancreas-associated transcription factor 1a (PTF1A).